Iovance Biotherapeutics, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP IOVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

4,948,614

Value ($000)

13,510

Weight

0.0%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	13,510	0.0%	4,948,614	12/31/2025
2025 Q3	11/14/2025	7,175	0.0%	3,306,516	9/30/2025
2025 Q2	8/14/2025	3,563	0.0%	2,071,472	6/30/2025
2025 Q1	5/14/2025	6,001	0.0%	1,802,193	3/31/2025
2024 Q4	2/14/2025	19,704	0.0%	2,662,695	12/31/2024
2024 Q3	11/14/2024	13,277	0.0%	1,413,917	9/30/2024
2024 Q2	8/15/2024	7,953	0.0%	991,649	6/30/2024
2024 Q1	5/7/2024	26,928	0.0%	1,817,000	3/31/2024
2023 Q4	2/14/2024	12,999	0.0%	1,598,930	12/31/2023
2023 Q3	11/14/2023	5,665	0.0%	1,245,037	9/30/2023
2023 Q2	8/11/2023	2,562	0.0%	363,983	6/30/2023
2023 Q1	5/16/2023	3,722	0.0%	609,175	3/31/2023
2022 Q4	2/14/2023	1,225	0.0%	191,748	12/31/2022
2022 Q3	11/14/2022	2,985	0.0%	311,623	9/30/2022
2022 Q2	8/15/2022	1,251	0.0%	113,280	6/30/2022
2022 Q1	5/16/2022	6,962	0.0%	418,153	3/31/2022
2021 Q4	2/14/2022	13,268	0.0%	695,000	12/31/2021
2021 Q3	11/15/2021	15,315	0.0%	621,039	9/30/2021
2021 Q2	8/11/2021	21,228	0.0%	815,848	6/30/2021
2021 Q1	5/17/2021	4,150	0.0%	131,089	3/31/2021
2020 Q4	2/16/2021	3,383	0.0%	72,909	12/31/2020
2020 Q3	11/16/2020	24,852	0.0%	754,937	9/30/2020
2020 Q2	8/14/2020	13,738	0.0%	500,485	6/30/2020
2020 Q1	5/15/2020	19,828	0.0%	662,361	3/31/2020